Literature DB >> 20035895

NFATc1: functions in osteoclasts.

Qingxiao Zhao1, Xi Wang, Yuehua Liu, Aimin He, Ruokun Jia.   

Abstract

NFATc1 is an important transcription factor which is critical for lineage selection in T-cell differentiation, cardiac valve morphogenesis, lymphatic endothelial development, osteoblast differentiation and osteoclastogenesis. Especially, it is a master regulator of RANKL-induced osteoclast differentiation and plays a pivotal role in osteoclast fusion and osteoclast activation via up-regulation of various genes responsible for osteoclast adhesion, migration, acidification, degradation of inorganic and organic bone matrix. In the present review, some of the known features of NFATc1 such as structure, function and its roles in physiological or pathophysiological processes are highlighted. 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20035895     DOI: 10.1016/j.biocel.2009.12.018

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  60 in total

1.  A marine fungus-derived nitrobenzoyl sesquiterpenoid suppresses receptor activator of NF-κB ligand-induced osteoclastogenesis and inflammatory bone destruction.

Authors:  Yanhui Tan; Wende Deng; Yueyang Zhang; Minhong Ke; Binhua Zou; Xiaowei Luo; Jianbin Su; Yiyuan Wang; Jialan Xu; Kutty Selva Nandakumar; Yonghong Liu; Xuefeng Zhou; Xiaojuan Li
Journal:  Br J Pharmacol       Date:  2020-08-11       Impact factor: 8.739

2.  Andrographolide suppresses RANKL-induced osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo.

Authors:  Z J Zhai; H W Li; G W Liu; X H Qu; B Tian; W Yan; Z Lin; T T Tang; A Qin; K R Dai
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

3.  Role of heme oxygenase-1 in postnatal differentiation of stem cells: a possible cross-talk with microRNAs.

Authors:  Magdalena Kozakowska; Krzysztof Szade; Jozef Dulak; Alicja Jozkowicz
Journal:  Antioxid Redox Signal       Date:  2014-01-30       Impact factor: 8.401

Review 4.  DC-STAMP: A Key Regulator in Osteoclast Differentiation.

Authors:  Ya-Hui Chiu; Christopher T Ritchlin
Journal:  J Cell Physiol       Date:  2016-06-14       Impact factor: 6.384

5.  Overexpression of spermidine/spermine N1-acetyltransferase impairs osteoblastogenesis and alters mouse bone phenotype.

Authors:  Sini Pirnes-Karhu; Jorma Määttä; Mikko Finnilä; Leena Alhonen; Anne Uimari
Journal:  Transgenic Res       Date:  2014-09-18       Impact factor: 2.788

6.  A vitronectin-derived peptide reverses ovariectomy-induced bone loss via regulation of osteoblast and osteoclast differentiation.

Authors:  Seung-Ki Min; Hyun Ki Kang; Sung Youn Jung; Da Hyun Jang; Byung-Moo Min
Journal:  Cell Death Differ       Date:  2017-09-22       Impact factor: 15.828

7.  FOXO1 mediates RANKL-induced osteoclast formation and activity.

Authors:  Yu Wang; Guangyu Dong; Hyeran Helen Jeon; Mohamad Elazizi; Lan B La; Alhassan Hameedaldeen; E Xiao; Chen Tian; Sarah Alsadun; Yongwon Choi; Dana T Graves
Journal:  J Immunol       Date:  2015-02-18       Impact factor: 5.422

8.  Ameloblastin modulates osteoclastogenesis through the integrin/ERK pathway.

Authors:  Xuanyu Lu; Yoshihiro Ito; Phimon Atsawasuwan; Smit Dangaria; Xiulin Yan; Tuojiang Wu; Carla A Evans; Xianghong Luan
Journal:  Bone       Date:  2013-02-04       Impact factor: 4.398

Review 9.  Targeting tumor microenvironment with silibinin: promise and potential for a translational cancer chemopreventive strategy.

Authors:  Gagan Deep; Rajesh Agarwal
Journal:  Curr Cancer Drug Targets       Date:  2013-06       Impact factor: 3.428

10.  Deletion of CD74, a putative MIF receptor, in mice enhances osteoclastogenesis and decreases bone mass.

Authors:  Se Hwan Mun; Hee Yeon Won; Paula Hernandez; Hector Leonardo Aguila; Sun-Kyeong Lee
Journal:  J Bone Miner Res       Date:  2013-04       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.